[1]
|
Hogea, S.-P., et al. (2020) Risk Factors of Chronic Obstructive Pulmonary Disease Exacerbations. The Clinical Respiratory Journal, 14, 183-197. https://doi.org/10.1111/crj.13129
|
[2]
|
Ritchie, A.I. and Wedzicha, J.A. (2020) Definition, Causes, Pathogenesis, and Consequences of Chronic Obstructive Pulmonary Disease Exacerbations. Clinics in Chest Medicine, 41, 421-438. https://doi.org/10.1016/j.ccm.2020.06.007
|
[3]
|
Roos, A.B., Sethi, S., Nikota, J., et al. (2015) IL-17A and the Promotion of Neutrophilia in Acute Exacerbation of Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine, 192, 428-437.
https://doi.org/10.1164/rccm.201409-1689OC
|
[4]
|
Gong, C., Yang, Y., Chen, M. and Xie, Z. (2020) Effect of Procalcitonin on the Prognosis of Patients with COPD. Biomedical Reports, 12, 313-318. https://doi.org/10.3892/br.2020.1298
|
[5]
|
Agassandian, M., Shurin, G.V., Ma, Y. and Shurin, M.R. (2014) C-Reactive Protein and Lung Diseases. The International Journal of Biochemistry & Cell Biology, 53, 77-88. https://doi.org/10.1016/j.biocel.2014.05.016
|
[6]
|
López-Campos, J.L., Calero, C., Rojano, B., et al. (2013) C-Reactive Protein and Serum Amyloid a Overexpression in Lung Tissues of Chronic Obstructive Pulmonary Disease Patients: A Case-Control Study. International Journal of Medical Sciences, 10, 938-947. https://doi.org/10.7150/ijms.6152
|
[7]
|
Prucha, M., Bellingan, G. and Zazula, R. (2015) Sepsis Biomarkers. Clinica Chimica Acta, 440, 97-103.
https://doi.org/10.1016/j.cca.2014.11.012
|
[8]
|
刘伟娜. CD64感染指数、BODE指数与降钙素原在慢阻肺患者中的水平变化[J]. 医学信息, 2019, 32(6): 125-127.
|
[9]
|
Falsey, A.R., Becker, K.L., Swinburne, A.J., et al. (2012) Utility of Serum Procalcitonin Values in Patients with Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Cautionary Note. International Journal of Chronic Obstructive Pulmonary Disease, 7, 127-135. https://doi.org/10.2147/COPD.S29149
|
[10]
|
Rammaert, B., Verdier, N., Cavestri, B., et al. (2009) Procalcitonin as a Prognostic Factor in Severe Acute Exacerbation of Chronic Obstructive Pulmonary Disease. Respirology, 14, 969-974.
https://doi.org/10.1111/j.1440-1843.2009.01597.x
|
[11]
|
Neuville, M., Vinclair, C., Cally, R. and Bouadma, L. (2019) Place des biomarqueurs dans la prise en charge des infections pulmonaires [Place of Biomarkers in the Management of Pulmonary Infections]. Revue des Maladies Respiratoires, 36, 405-414. https://doi.org/10.1016/j.rmr.2018.09.003
|
[12]
|
张俣, 王利平, 李晓萍, 等. 降钙素原水平变化与慢性阻塞性肺疾病BODE指数的关系[J]. 临床肺科杂志, 2017, 22(1): 54-57.
|
[13]
|
Çolak, A., Yılmaz, C., Toprak, B. and Aktoğu, S. (2017) Procalcitonin and CRP as Biomarkers in Discrimination of Community-Acquired Pneumonia and Exacerbation of COPD. Journal of Medical Biochemistry, 36, 122-126.
https://doi.org/10.1515/jomb-2017-0011
|
[14]
|
Shahriary, A., Panahi, Y., Shirali, S. and Rahmani, H. (2017) Relationship of Serum Levels of Interleukin 6, Interleukin 8, and C-Reactive Protein with Forced Expiratory Volume in First Second in Patients with Mustard Lung and Chronic Obstructive Pulmonary Diseases: Systematic Review and Meta-Analysis. Advances in Dermatology and Allergology, 34, 192-198. https://doi.org/10.5114/ada.2017.67841
|
[15]
|
Sarioglu, N., Alpaydin, A.O., Coskun, A.S., et al. (2010) Relationship between BODE Index, Quality of Life and Inflammatory Cytokines in COPD Patients. Multidisciplinary Respiratory Medicine, 5, 84-91.
https://doi.org/10.1186/2049-6958-5-2-84
|
[16]
|
Liu, S.F., Wang, C.C., Chin, C.H., et al. (2011) High Value of Combined Serum C-Reactive Protein and BODE Score for Mortality Prediction in Patients with Stable COPD. Archivos de Bronconeumología, 47, 427-432.
https://doi.org/10.1016/j.arbr.2011.04.010
|
[17]
|
Wang, C., Ding, Y., Shen, B., et al. (2017) Altered Gray Matter Volume in Stable Chronic Obstructive Pulmonary Disease with Subclinical Cognitive Impairment: An Exploratory Study. Neurotoxicity Research, 31, 453-463.
https://doi.org/10.1007/s12640-016-9690-9
|
[18]
|
Bozinovski, S., Hutchinson, A., Thompson, M., et al. (2008) Serum Amyloid A Is a Biomarker of Acute Exacerbations of Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine, 177, 269-278.
https://doi.org/10.1164/rccm.200705-678OC
|
[19]
|
Lin, T.L., Chen, W.W., Ding, Z.R., Wei, S.C., Huang, M.L. and Li, C.H. (2019) Correlations between Serum Amyloid A, C-Reactive Protein and Clinical Indices of Patients with Acutely Exacerbated Chronic Obstructive Pulmonary Disease. Journal of Clinical Laboratory Analysis, 33, e22831. https://doi.org/10.1002/jcla.22831
|
[20]
|
黎艳聪, 张杰斯, 郭超文, 等. 血清淀粉样蛋白A在慢性阻塞性肺疾病急性加重期中的应用价值[J]. 实用医学杂志, 2017, 33(14): 2349-2352.
|